Jason Cook
Co-founder & Chief Executive Officer Olfax Medical
Seminars
Tuesday 2nd February 2027
From Nose-to-Brain Theory to Clinical Success: Building a Development Strategy That Investors, Regulators, & Partners Will Support
1:00 pm
This highly practical workshop is designed for teams looking to understand what separates successful intranasal development programs from those that fail. Through open discussion, attendees will explore how to build robust development strategies that generate confidence among investors, partners, regulators, and future commercial stakeholders.
Discussion Areas:
- What evidence convinces investors to fund intranasal programs to de-risk programs?
- Understanding reimbursement and commercialization requirements and avoiding common development
- Understand how large pharma evaluates emerging intranasal technologies, platforms, and therapeutic programs when considering partnership or licensing opportunities
- Identify the scientific, clinical, and regulatory milestones that increase confidence and help transform promising innovation into a commercially attractive asset
- Learn how developers can reduce perceived development risk, strengthen differentiation, and build
Wednesday 3rd February 2027
Delivering Beyond the Olfactory Region: Understanding Multiple Pathways to the CNS
1:30 pm
- Explore how targeted intranasal access to the sphenopalatine ganglion may offer an alternative approach to influencing CNS-relevant pathways beyond traditional olfactory-focused delivery strategies
- Understand the development journey from clinician-administered SPG procedures to scalable intranasal drug-device combination products capable of improving patient access and treatment convenience
- Learn how delivery strategy, formulation design, and device development must work together to support successful clinical translation, regulatory development, and future commercialization opportunities
